Bliss GVS Pharma Ltd
ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD
Stock has been generating better return on equity than bank FD
Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company
Stock doesn't offer attractive dividend returns
Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock
Good time to consider, as stock is not in overbought zone
No Red FlagsASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list or with high pledged promoter holding should be handled with caution. Unsolicited tips are sometimes circulated to manipulate the market. Beware of these stocks
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
News & Opinions
Corporate Radar: SKF India, Whirlpool to turn ex-dividend; Tata Steel, Britannia AGMs; stock splits and more
1 week ago•Economic Times
Thyrocare Technologies Ltd leads gainers in ‘A’ group
4 weeks ago•Business Standard
Bliss GVS Pharma consolidated net profit rises 214.58% in the March 2022 quarter
2 months ago•Business Standard
Bliss GVS Pharma gets revision in credit ratings by Infomerics; Stock trades flat
5 months ago•India Infoline
Bliss GVS Pharma consolidated net profit rises 31.38% in the September 2021 quarter
8 months ago•Business Standard
Bliss GVS Pharma purchases immovable property from JMFARC
9 months ago•India Infoline
Bliss GVS Pharma fixes record date for final dividend
10 months ago•Business Standard
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Current price is less than the intrinsic value